Register entry
GlaxoSmithKline Biologicals SA
- Registered sites
- 19
- Drug products
- 126
- Live patents
- 63
- Countries
- 9
- Base
- United Kingdom
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackagingparticle size reductionsterilize
Sites
Facilities
19| Site | Location | Operations | FEI |
|---|---|---|---|
| GlaxoSmithKline Biologicals SA | RixensartBelgium | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3002875226 |
| GlaxoSmithKline Biologicals SA | WavreBelgium | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3003973577 |
| ID Biomedical Corporation of Quebec | Ste-FoyCanada | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3004835647 |
| SmithKline Beecham Pharma GmbH & Co. KG (dba GlaxoSmithKline Biologicals) | DresdenGermany | Analytical testing, Finished drug manufacture, Packaging, sterilize | 3004835618 |
| GSK Vaccines GmbH | MarburgGermany | Analytical testing, Finished drug manufacture, Packaging | 3001314775 |
| Glaxo Wellcome S.A. | Aranda De DueroSpain | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3004195227 |
| Glaxo Wellcome Production | EvreuxFrance | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, particle size reduction | 3002807436 |
| GlaxoSmithKline Biologicals | Saint-Amand Les EauxFrance | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3014752610 |
| Glaxo Operations UK Ltd | Barnard CastleUnited Kingdom | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3002807078 |
| Glaxo Operations UK Ltd | MontroseUnited Kingdom | Analytical testing, Active ingredient (API) manufacture | 3003215057 |
| Glaxo Operations UK Ltd | StevenageUnited Kingdom | Analytical testing | 3009763376 |
| Glaxo Operations UK Ltd | WareUnited Kingdom | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, particle size reduction | 3003262904 |
| GlaxoSmithKline Vaccines Srl | SOVICILLE (ROSIA )Italy | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3006738517 |
| GlaxoSmithKline Manufacturing SpA | San PoloItaly | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, sterilize | 3002807114 |
| GSK Vaccines S.r.l. | SienaItaly | Analytical testing | 3007780504 |
| Glaxo Wellcome Manufacturing Pte. Ltd | JurongSingapore | Analytical testing, Active ingredient (API) manufacture, particle size reduction | 3002807079 |
| GlaxoSmithKline LLC | Conshohocken, PAUnited States | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, sterilize | 3004055938 |
| Corixa Corporation | Marietta, PAUnited States | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3007726770 |
| GlaxoSmithKline LLC | Zebulon, NCUnited States | Analytical testing, Labelling, Finished drug manufacture, Packaging | 1033964 |
Exclusivity
Patents
63Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| BLUJEPA | GEPOTIDACIN MESYLATE | Feb 2029 |
| BLUJEPA | GEPOTIDACIN MESYLATE | Aug 2035 |
| BLUJEPA | GEPOTIDACIN MESYLATE | Dec 2042 |
| BREXAFEMME | IBREXAFUNGERP CITRATE | Aug 2030 |
| BREXAFEMME | IBREXAFUNGERP CITRATE | Jan 2035 |
| BREXAFEMME | IBREXAFUNGERP CITRATE | Jun 2039 |
| LAMICTAL XR | LAMOTRIGINE | Jan 2029 |
| OJJAARA | MOMELOTINIB DIHYDROCHLORIDE | Jan 2035 |
| OJJAARA | MOMELOTINIB DIHYDROCHLORIDE | Jun 2035 |
| OJJAARA | MOMELOTINIB DIHYDROCHLORIDE | Aug 2039 |
| OJJAARA | MOMELOTINIB DIHYDROCHLORIDE | Dec 2040 |
| UTEBZI | TEBIPENEM PIVOXIL HYDROBROMIDE | Dec 2037 |
| UTEBZI | TEBIPENEM PIVOXIL HYDROBROMIDE | Feb 2038 |
| ZEJULA | NIRAPARIB TOSYLATE | Aug 2027 |
| ZEJULA | NIRAPARIB TOSYLATE | Apr 2029 |
| ZEJULA | NIRAPARIB TOSYLATE | Mar 2031 |
| ZEJULA | NIRAPARIB TOSYLATE | Aug 2031 |
| ZEJULA | NIRAPARIB TOSYLATE | Mar 2038 |
| ZEJULA | NIRAPARIB TOSYLATE | Jan 2039 |
Catalogue
Marketed products
126Showing 126 of 126.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| ADVAIR DISKUS | fluticasone propionate and salmeterol | POWDER | NDA |
| ADVAIR DISKUS | fluticasone propionate and salmeterol | POWDER | NDA |
| ADVAIR DISKUS | fluticasone propionate and salmeterol | POWDER | NDA |
| ADVAIR HFA | fluticasone propionate and salmeterol xinafoate | AEROSOL, METERED | NDA |
| ADVAIR HFA | fluticasone propionate and salmeterol xinafoate | AEROSOL, METERED | NDA |
| ADVAIR HFA | fluticasone propionate and salmeterol xinafoate | AEROSOL, METERED | NDA |
| AS03 | AS03 | INJECTION, SOLUTION | UNAPPROVED DRUG OTHER |
| Anoro Ellipta | umeclidinium bromide and vilanterol trifenatate | POWDER | NDA |
| Arepanrix | Influenza A H5 Monovalent Vaccine | KIT | BLA |
| Arexvy | Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted | KIT | BLA |
| Arexvy | Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted | KIT | BLA |
| Arexvy | Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted | KIT | BLA |
| Arnuity Ellipta | fluticasone furoate | POWDER | NDA |
| Arnuity Ellipta | fluticasone furoate | POWDER | NDA |
| Arnuity Ellipta | fluticasone furoate | POWDER | NDA |
| BENLYSTA | belimumab | SOLUTION | BLA |
| BENLYSTA | belimumab | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BLA |
| BENLYSTA | belimumab | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BLA |
| BOOSTRIX | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed | SUSPENSION | BLA |
| Bexsero | NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN | INJECTION, SUSPENSION | BLA |
| Blenrep | belantamab mafodotin | INJECTION, POWDER, FOR SOLUTION | BLA |
| Blujepa | gepotidacin | TABLET, FILM COATED | NDA |
| Breo Ellipta | fluticasone furoate and vilanterol trifenatate | POWDER | NDA |
| Breo Ellipta | fluticasone furoate and vilanterol trifenatate | POWDER | NDA |
| Breo Ellipta | fluticasone furoate and vilanterol trifenatate | POWDER | NDA |
| - | Depemokimab | LIQUID | BULK INGREDIENT |
| - | Dolutegravir and Lamivudine | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| ENGERIX-B | Hepatitis B Vaccine (Recombinant) | INJECTION, SUSPENSION | BLA |
| ENGERIX-B | Hepatitis B Vaccine (Recombinant) | INJECTION, SUSPENSION | BLA |
| Exdensur | depemokimab | INJECTION, SOLUTION | BLA |
| FLUARIX 2026/2027 | influenza virus vaccine | SUSPENSION | BLA |
| HAVRIX | Hepatitis A Vaccine | INJECTION, SUSPENSION | BLA |
| HAVRIX | Hepatitis A Vaccine | INJECTION, SUSPENSION | BLA |
| Hiberix | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) | KIT | BLA |
| Hiberix | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) | KIT | BLA |
| IMITREX | sumatriptan | INJECTION | NDA |
| IMITREX | sumatriptan | INJECTION | NDA |
| IMITREX | sumatriptan | TABLET, FILM COATED | NDA |
| IMITREX | sumatriptan | TABLET, FILM COATED | NDA |
| IMITREX | sumatriptan | TABLET, FILM COATED | NDA |
| IMITREX | sumatriptan | INJECTION | NDA |
| INFANRIX | Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed | SUSPENSION | BLA |
| Incruse Ellipta | umeclidinium | AEROSOL, POWDER | NDA |
| Jemperli | dostarlimab | INJECTION | BLA |
| Jesduvroq | daprodustat | TABLET, FILM COATED | NDA |
| Jesduvroq | daprodustat | TABLET, FILM COATED | NDA |
| Jesduvroq | daprodustat | TABLET, FILM COATED | NDA |
| Jesduvroq | daprodustat | TABLET, FILM COATED | NDA |
| Jesduvroq | daprodustat | TABLET, FILM COATED | NDA |
| KINRIX | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine | INJECTION, SUSPENSION | BLA |
| Krintafel | tafenoquine succinate | TABLET, FILM COATED | NDA |
| LAMICTAL | lamotrigine | TABLET, FOR SUSPENSION | NDA |
| LAMICTAL | lamotrigine | TABLET, FOR SUSPENSION | NDA |
| LAMICTAL | lamotrigine | KIT | NDA |
| LAMICTAL | lamotrigine | TABLET | NDA |
| LAMICTAL | lamotrigine | TABLET | NDA |
| LAMICTAL | lamotrigine | TABLET | NDA |
| LAMICTAL | lamotrigine | TABLET | NDA |
| LAMICTAL | lamotrigine | TABLET, FOR SUSPENSION | NDA |
| LAMICTAL | lamotrigine | KIT | NDA |
| LAMICTAL ODT | lamotrigine | TABLET, ORALLY DISINTEGRATING | NDA |
| LAMICTAL ODT | lamotrigine | TABLET, ORALLY DISINTEGRATING | NDA |
| LAMICTAL ODT | lamotrigine | TABLET, ORALLY DISINTEGRATING | NDA |
| LAMICTAL ODT | lamotrigine | TABLET, ORALLY DISINTEGRATING | NDA |
| LAMICTAL ODT | lamotrigine | KIT | NDA |
| LAMICTAL ODT | lamotrigine | KIT | NDA |
| LAMICTAL ODT | lamotrigine | KIT | NDA |
| LAMICTAL XR | lamotrigine | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| LAMICTAL XR | lamotrigine | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| LAMICTAL XR | lamotrigine | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| LAMICTAL XR | lamotrigine | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| LAMICTAL XR | lamotrigine | KIT | NDA |
| LAMICTAL XR | lamotrigine | KIT | NDA |
| LAMICTAL XR | lamotrigine | KIT | NDA |
| LAMICTAL XR | lamotrigine | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| LAMICTAL XR | lamotrigine | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| MALARONE | atovaquone and proguanil hydrochloride | TABLET, FILM COATED | NDA |
| MALARONE | atovaquone and proguanil hydrochloride | TABLET, FILM COATED | NDA |
| MEPRON | atovaquone | SUSPENSION | NDA |
| MEPRON | atovaquone | SUSPENSION | NDA |
| Menveo | Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine | INJECTION, SOLUTION | BLA |
| Menveo | Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine | KIT | BLA |
| Nucala | mepolizumab | INJECTION, POWDER, FOR SOLUTION | BLA |
| Nucala | mepolizumab | INJECTION, SOLUTION | BLA |
| Nucala | mepolizumab | INJECTION, SOLUTION | BLA |
| Ojjaara | Momelotinib | TABLET | NDA |
| Ojjaara | Momelotinib | TABLET | NDA |
| Ojjaara | Momelotinib | TABLET | NDA |
| PEDIARIX | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined | INJECTION, SUSPENSION | BLA |
| PENMENVY | Meningococcal (Groups A, B, C, W and Y) | KIT | BLA |
| Priorix | Measels, Mumps, and Rubella Vaccine, Live | KIT | BLA |
| RELENZA | zanamivir | POWDER | NDA |
| Rotarix | Rotavirus Vaccine, Live, Oral | SOLUTION | BLA |
| SEREVENT DISKUS | salmeterol xinafoate | POWDER, METERED | NDA |
| Shingrix | Zoster Vaccine Recombinant, Adjuvanted | KIT | BLA |
| Shingrix | Zoster Vaccine Recombinant, Adjuvanted | INJECTION, SOLUTION | BLA |
| TWINRIX | Hepatitis A and Hepatitis B (Recombinant) Vaccine | INJECTION, SUSPENSION | BLA |
| Trelegy Ellipta | fluticasone furoate, umeclidinium bromide and vilanterol trifenatate | POWDER | NDA |
| Trelegy Ellipta | fluticasone furoate, umeclidinium bromide and vilanterol trifenatate | POWDER | NDA |
| VALTREX | valacyclovir hydrochloride | TABLET, FILM COATED | NDA |
| VALTREX | valacyclovir hydrochloride | TABLET, FILM COATED | NDA |
| VENTOLIN HFA | albuterol sulfate | AEROSOL, METERED | NDA |
| WELLBUTRIN SR | bupropion hydrochloride | TABLET, FILM COATED | NDA |
| WELLBUTRIN SR | bupropion hydrochloride | TABLET, FILM COATED | NDA |
| WELLBUTRIN SR | bupropion hydrochloride | TABLET, FILM COATED | NDA |
| ZEJULA | niraparib | TABLET, FILM COATED | NDA |
| ZEJULA | niraparib | TABLET, FILM COATED | NDA |
| ZEJULA | niraparib | TABLET, FILM COATED | NDA |
| - | belantamab mafodotin | LIQUID | BULK INGREDIENT |
| - | belimumab | LIQUID | BULK INGREDIENT |
| - | doxorubicin hydrochloride | INJECTION, SUSPENSION, LIPOSOMAL | DRUG FOR FURTHER PROCESSING |
| - | lamotrigine | TABLET, FILM COATED, EXTENDED RELEASE | DRUG FOR FURTHER PROCESSING |
| - | lamotrigine | TABLET, FILM COATED, EXTENDED RELEASE | DRUG FOR FURTHER PROCESSING |
| - | lamotrigine | TABLET, FILM COATED, EXTENDED RELEASE | DRUG FOR FURTHER PROCESSING |
| - | lamotrigine | TABLET, FILM COATED, EXTENDED RELEASE | DRUG FOR FURTHER PROCESSING |
| - | lamotrigine | TABLET | DRUG FOR FURTHER PROCESSING |
| - | lamotrigine | TABLET | DRUG FOR FURTHER PROCESSING |
| - | mepolizumab | LIQUID | BULK INGREDIENT |
| - | mepolizumab | LIQUID | BULK INGREDIENT |
| - | mepolizumab | LIQUID | BULK INGREDIENT |
| - | raxibacumab | LIQUID | BULK INGREDIENT |
| - | sumatriptan | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | sumatriptan | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | sumatriptan | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | trametinib | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | trametinib | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.